metoprolol has been researched along with Atheroma in 3 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "It has been shown that oxidative stress may play an important role in the development of atherosclerosis, and carvedilol has the capacity of reducing oxidative stress." | 7.78 | Carvedilol reduces the severity of atherosclerosis in apolipoprotein E-deficient mice via reducing superoxide production. ( Fujita, M; Hirano, E; Kimura, T; Kishimoto, C; Shimada, K, 2012) |
| "Atherosclerosis was assessed in thoracic aorta and aortic root." | 5.40 | Metoprolol reduces proinflammatory cytokines and atherosclerosis in ApoE-/- mice. ( Bergström, GM; Bernberg, E; Johansson, ME; Ulleryd, MA; Yang, LJ, 2014) |
| "It has been shown that oxidative stress may play an important role in the development of atherosclerosis, and carvedilol has the capacity of reducing oxidative stress." | 3.78 | Carvedilol reduces the severity of atherosclerosis in apolipoprotein E-deficient mice via reducing superoxide production. ( Fujita, M; Hirano, E; Kimura, T; Kishimoto, C; Shimada, K, 2012) |
| "Atherosclerosis was assessed in thoracic aorta and aortic root." | 1.40 | Metoprolol reduces proinflammatory cytokines and atherosclerosis in ApoE-/- mice. ( Bergström, GM; Bernberg, E; Johansson, ME; Ulleryd, MA; Yang, LJ, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ulleryd, MA | 1 |
| Bernberg, E | 1 |
| Yang, LJ | 1 |
| Bergström, GM | 1 |
| Johansson, ME | 1 |
| Ostling, G | 1 |
| Gonçalves, I | 1 |
| Wikstrand, J | 1 |
| Berglund, G | 1 |
| Nilsson, J | 1 |
| Hedblad, B | 1 |
| Shimada, K | 1 |
| Hirano, E | 1 |
| Kimura, T | 1 |
| Fujita, M | 1 |
| Kishimoto, C | 1 |
1 trial available for metoprolol and Atheroma
| Article | Year |
|---|---|
Long-term treatment with low-dose metoprolol CR/XL is associated with increased plaque echogenicity: the Beta-blocker Cholesterol-lowering Asymptomatic Plaque Study (BCAPS).
Topics: Adrenergic beta-Antagonists; Aged; Carotid Artery Diseases; Double-Blind Method; Fatty Acids, Monoun | 2011 |
2 other studies available for metoprolol and Atheroma
| Article | Year |
|---|---|
Metoprolol reduces proinflammatory cytokines and atherosclerosis in ApoE-/- mice.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Aorta, Thoracic; Apolipoproteins E; Atherosclerosis | 2014 |
Carvedilol reduces the severity of atherosclerosis in apolipoprotein E-deficient mice via reducing superoxide production.
Topics: Adrenergic beta-Antagonists; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Blood Pressure; Car | 2012 |